|
WO2020168168A1
|
|
Compositions and methods for diagnosing and assessing rheumatoid arthritis
|
|
TW201613981A
|
|
Compositions and methods for the diagnosis of rheumatoid arthritis
|
|
US2017199187A1
|
|
Compositions and methods for the diagnosis of systemic autoimmune disease
|
|
WO2013163105A1
|
|
Biomarkers for hepatocellular carcinoma
|
|
CA2840590A1
|
|
Method for increasing specificity of diagnostic tests for autoimmune diseases
|
|
WO2011130546A1
|
|
Methods for differentiating between crohn's disease and other inflammatory bowel conditions
|
|
CA2808611A1
|
|
Detecting circulating cartilage oligomeric matrix protein in liver cirrhosis
|
|
WO2010085763A1
|
|
Methods for detecting antibodies associated with autoimmune diseases utilizing a three dimensionally heterogeneous peptide antigen
|
|
WO2008060394A2
|
|
Methods and assays for detecting gp73-specific autoantibodies
|
|
CA2658824A1
|
|
Compositions and methods for diagnosing patients with acute atherosclerotic syndromes
|
